News

JCO publishes special issue on head and neck cancers


 

References

The Journal of Clinical Oncology has published a special series issue on head and neck cancers, with a major focus on squamous cell carcinomas arising from the upper aerodigestive tract mucosa.

“In addition, we also address nasopharyngeal cancer, nonmelanoma cutaneous head and neck cancer, and squamous carcinoma of the neck of unknown primary origin,” writes Dr. Danny Rischin of the Peter MacCallum Cancer Centre and University of Melbourne, Victoria, Australia, and associates in an overview for the issue.

©xrender/Thinkstock.com

The 16 articles in the issue provide the reader with an overview of current evidence and management, recent developments, and insights into future directions, they write.

It was only recently that human papillomavirus was identified as a cause of oropharyngeal cancer and that HPV-associated oropharyngeal cancer was found to have its own unique biologic signature. Three articles are included in the series that review the rapidly evolving understanding of HPV-related head and neck cancers.

Find the overview and series of 16 articles in the Sept. 7 issue of the Journal of Clinical Oncology.

lfranki@frontlinemedcom.com

Recommended Reading

RAI given to thyroid CA patients does not increase their breast malignancy occurrence, recurrence
MDedge Hematology and Oncology
Gene-testing predictive value can depend on institutional cancer prevalence
MDedge Hematology and Oncology
New guidelines focus on pediatric thyroid nodules and cancer
MDedge Hematology and Oncology
Moderate THST was most effective at treating thyroid cancer
MDedge Hematology and Oncology
ASCO 2015: from data and learning, to daily practice
MDedge Hematology and Oncology
A weekly speech and language therapy service for head and neck radiotherapy patients during treatment: maximizing accessibility and efficiency
MDedge Hematology and Oncology
Harnessing new data on immunotherapies
MDedge Hematology and Oncology
Similar outcomes for salvage vs. planned surgery after chemoradiotherapy in esophageal cancer
MDedge Hematology and Oncology
Persistent HPV16 DNA in oral rinse signaled oropharyngeal cancer’s return
MDedge Hematology and Oncology
ESTIMABL trial: Current rhTSH cost outweighs benefits
MDedge Hematology and Oncology